<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39311201</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2036-7430</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Infectious disease reports</Title><ISOAbbreviation>Infect Dis Rep</ISOAbbreviation></Journal><ArticleTitle>Comparative Epidemiological and Clinical Outcomes on COVID-19 and Seasonal Influenza Hospitalized Patients during 2023.</ArticleTitle><Pagination><StartPage>783</StartPage><EndPage>793</EndPage><MedlinePgn>783-793</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/idr16050060</ELocationID><Abstract><AbstractText>COVID-19 and influenza are highly contagious respiratory viral diseases and priority global public health concerns. We conducted a retrospective observational study of COVID-19 and/or influenza hospitalized cases, during 2023. We identified 170 influenza cases, 150 COVID-19 cases and 3 co-infections. Overall, 29.10% of patients had at least one COVID-19 vaccine dose and 4.6% received the seasonal Flu vaccine. The demographic data found older patients in the COVID-19 group and a higher index of the comorbidities, mainly due to chronic heart diseases, hypertension, and diabetes. Fever, chills, and rhinorrhea were more frequently related to influenza, while cough was prevalent in COVID-19. Antibiotics were more used in influenza than COVID-19, either pre-hospital or in-hospital. The mortality rate within the first 30 days from the onset of the respiratory infection was higher in influenza compared to COVID-19. We concluded that the COVID-19 clinical picture in hospitalized patients is changing to influenza-like symptoms. The evolution is variable, related to chronic comorbidities, but influenza had more frequent severe forms. All through 2023, due to poor vaccination rates, COVID-19 and influenza have continued to cause numerous hospitalizations, and a new strategy for efficient vaccinations is required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vlase</LastName><ForeName>Constantin-Marinel</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Doctoral Studies in Biomedical Sciences, "Dunarea de Jos" University Galati, 800008 Galati, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Military Hospital "Dr. Aristide Serfioti" Galați, 800008 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuparu Cretu</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0626-2023</Identifier><AffiliationInfo><Affiliation>Medical Department, "Dunarea de Jos" University Galati, 800008 Galati, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic Emergency Children Hospital, 800487 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasile</LastName><ForeName>Mihaela-Camelia</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Doctoral Studies in Biomedical Sciences, "Dunarea de Jos" University Galati, 800008 Galati, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Clinic II, Infectious Diseases Clinic Hospital Galati, 800179 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popovici</LastName><ForeName>George-Cosmin</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Doctoral Studies in Biomedical Sciences, "Dunarea de Jos" University Galati, 800008 Galati, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pneumology Department II, Pneumophtisiology Hospital Galati, 800170 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbune</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4762-0755</Identifier><AffiliationInfo><Affiliation>Clinical Medical Department, "Dunarea de Jos" University Galati, 800008 Galati, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Clinic I, Infectious Diseases Clinic Hospital Galati, 800179 Galati, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Infect Dis Rep</MedlineTA><NlmUniqueID>101537203</NlmUniqueID><ISSNLinking>2036-7430</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword><Keyword MajorTopicYN="N">viral diseases</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311201</ArticleId><ArticleId IdType="pmc">PMC11417947</ArticleId><ArticleId IdType="doi">10.3390/idr16050060</ArticleId><ArticleId IdType="pii">idr16050060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Groves H.E., Piché-Renaud P.P., Peci A., Farrar D.S., Buckrell S., Bancej C., Sevenhuysen C., Campigotto A., Gubbay J.B., Morris S.K. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg. Health Am. 2021;1:100015. doi: 10.1016/j.lana.2021.100015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100015</ArticleId><ArticleId IdType="pmc">PMC8285668</ArticleId><ArticleId IdType="pubmed">34386788</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Jia M., Jiang M., Liu W., Yang J., Dai P., Sun Y., Qian J., Yang W., Feng L. Seesaw Effect Between COVID-19 and Influenza From 2020 to 2023 in World Health Organization Regions: Correlation Analysis. JMIR Public Health Surveill. 2023;9:e44970. doi: 10.2196/44970.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/44970</ArticleId><ArticleId IdType="pmc">PMC10263104</ArticleId><ArticleId IdType="pubmed">37191650</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Gong Y., Zhang C., Sun J., Wong G., Shi W., Liu W., Gao G.F., Bi Y. Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges. Innovation. 2022;3:100306. doi: 10.1016/j.xinn.2022.100306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2022.100306</ArticleId><ArticleId IdType="pmc">PMC9384331</ArticleId><ArticleId IdType="pubmed">35992368</ArticleId></ArticleIdList></Reference><Reference><Citation>Yewdell J.W. Antigenic drift: Understanding COVID-19. Immunity. 2021;54:2681–2687. doi: 10.1016/j.immuni.2021.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.11.016</ArticleId><ArticleId IdType="pmc">PMC8669911</ArticleId><ArticleId IdType="pubmed">34910934</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrrell C.S., Allen J.L.Y., Gkrania-Klotsas E. Influenza: Epidemiology and hospital management. Medicine. 2021;49:797–804. doi: 10.1016/j.mpmed.2021.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mpmed.2021.09.015</ArticleId><ArticleId IdType="pmc">PMC8624711</ArticleId><ArticleId IdType="pubmed">34849086</ArticleId></ArticleIdList></Reference><Reference><Citation>Varshney K., Pillay P., Mustafa A.D., Shen D., Adalbert J.R., Mahmood M.Q. A systematic review of the clinical characteristics of influenza-COVID-19 co-infection. Clin. Exp. Med. 2023;23:3265–3275. doi: 10.1007/s10238-023-01116-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01116-y</ArticleId><ArticleId IdType="pmc">PMC10618381</ArticleId><ArticleId IdType="pubmed">37326928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadashi M., Khaleghnejad S., Abedi Elkhichi P., Goudarzi M., Goudarzi H., Taghavi A., Vaezjalali M., Hajikhani B. COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis. Front. Med. 2021;8:681469. doi: 10.3389/fmed.2021.681469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.681469</ArticleId><ArticleId IdType="pmc">PMC8267808</ArticleId><ArticleId IdType="pubmed">34249971</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Z., Chen C., Li Y., Yan D., Zhang X., Jiang D., Yang S., Li L. Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis. Front. Public Health. 2021;9:773130. doi: 10.3389/fpubh.2021.773130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.773130</ArticleId><ArticleId IdType="pmc">PMC8703010</ArticleId><ArticleId IdType="pubmed">34957025</ArticleId></ArticleIdList></Reference><Reference><Citation>Decisions Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the Communicable Diseases and Related Special Health Issues to Be Covered by Epidemiological Surveillance as well as Relevant Case Definitions.  [(accessed on 2 December 2023)].  Official Journal of the European Union. Publications Office of the European Union: Luxembourg, 6 July 2018. L 170/1. Available online:  https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945.</Citation></Reference><Reference><Citation>Charlson M.E., Carrozzino D., Guidi J., Patierno C. Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother. Psychosom. 2022;91:8–35. doi: 10.1159/000521288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000521288</ArticleId><ArticleId IdType="pubmed">34991091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerul Sanatatii  Protocolul de Tratament al Infecției cu Virusul SARS-CoV-2. Monitorul Oficial, Partea I nr. 576 din 26 Iunie 2023.  [(accessed on 30 July 2023)].  Available online:  https://legislatie.just.ro/public/DetaliiDocument/271637.</Citation></Reference><Reference><Citation>Markov P.V., Ghafari M., Beer M., Lythgoe K., Simmonds P., Stilianakis N.I., Katzourakis A. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 2023;21:361–379. doi: 10.1038/s41579-023-00878-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00878-2</ArticleId><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada T., Zhou H., Dcosta B.M., Samanovic M.I., Mulligan M.J., Landau N.R. Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera. iScience. 2021;24:103341. doi: 10.1016/j.isci.2021.103341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103341</ArticleId><ArticleId IdType="pmc">PMC8541826</ArticleId><ArticleId IdType="pubmed">34723159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D.Y., Chin C.V., Kenney D., Tavares A.H., Khan N., Conway H.L., Liu G., Choudhary M.C., Gertje H.P., O’Connell A.K., et al. Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation. Nature. 2023;615:143–150. doi: 10.1038/s41586-023-05697-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05697-2</ArticleId><ArticleId IdType="pubmed">36630998</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Selvaraj P., Sangare K., Luan B., Wang T.T. Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice. Cell Rep. 2022;40:111359. doi: 10.1016/j.celrep.2022.111359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111359</ArticleId><ArticleId IdType="pmc">PMC9420700</ArticleId><ArticleId IdType="pubmed">36075211</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov P.V., Katzourakis A., Stilianakis N.I. Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity. Nat. Rev. Microbiol. 2022;20:251–252. doi: 10.1038/s41579-022-00722-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00722-z</ArticleId><ArticleId IdType="pmc">PMC8919145</ArticleId><ArticleId IdType="pubmed">35288685</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav S., Zaman K., Bashyal P., Bhatta R., Bhandari S., Mohanty A., Sah R. Newer emerging SARS-CoV-2 variant: Omicron EG.5. Ann. Med. Surg. 2023;85:5845–5846. doi: 10.1097/MS9.0000000000001386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MS9.0000000000001386</ArticleId><ArticleId IdType="pmc">PMC10718343</ArticleId><ArticleId IdType="pubmed">38098560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissling E., Maurel M., Emborg H.D., Whitaker H., McMenamin J., Howard J., Trebbien R., Watson C., Findlay B., Pozo F., et al. Interim 2022/23 influenza vaccine effectiveness: Six European studies, October 2022 to January 2023. Eurosurveillance. 2023;28:2300116. doi: 10.2807/1560-7917.ES.2023.28.21.2300116.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2023.28.21.2300116</ArticleId><ArticleId IdType="pmc">PMC10283457</ArticleId><ArticleId IdType="pubmed">37227299</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC  . Influenza Virus Characterization: Summary Report, Europe, March 2024. WHO Regional Office for Europe and Stockholm and European Centre for Disease Prevention and Control; Copenhagen, Denmark: 2024.  [(accessed on 1 May 2024)].  Available online:  https://www.ecdc.europa.eu/sites/default/files/documents/influenza-ECDC-WHO-Report-March-2024.pdf.</Citation></Reference><Reference><Citation>Malița M.A., Manolescu L.S.C., Perieanu V., Babiuc I., Marcov E.C., Ionescu C., Beuran I.A., Prasacu I., Perieanu M.V., Voinescu I., et al. COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population. PLoS ONE. 2024;19:e0299568. doi: 10.1371/journal.pone.0299568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0299568</ArticleId><ArticleId IdType="pmc">PMC10919663</ArticleId><ArticleId IdType="pubmed">38451954</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S., Nalla L.V., Sharma M., Sharma N., Singh A.A., Malim F.M., Ghatage M., Mukarram M., Pawar A., Parihar N., et al. Association of COVID-19 with Comorbidities: An Update. ACS Pharmacol. Transl. Sci. 2023;6:334–354. doi: 10.1021/acsptsci.2c00181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.2c00181</ArticleId><ArticleId IdType="pmc">PMC10000013</ArticleId><ArticleId IdType="pubmed">36923110</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasile M.C., Arbune A.A., Lupasteanu G., Vlase C.M., Popovici G.C., Arbune M. Epidemiologic and Clinic Characteristics of the First Wave of the COVID-19 Pandemic in Hospitalized Patients from Galați County. J. Clin. Med. 2021;10:4210. doi: 10.3390/jcm10184210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184210</ArticleId><ArticleId IdType="pmc">PMC8467201</ArticleId><ArticleId IdType="pubmed">34575321</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi S.H., Riahi S.M., Ebrahimzadeh A., Salmani F. Changes in symptoms and characteristics of COVID-19 patients across different variants: Two years study using neural network analysis. BMC Infect. Dis. 2023;23:838. doi: 10.1186/s12879-023-08813-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08813-9</ArticleId><ArticleId IdType="pmc">PMC10683353</ArticleId><ArticleId IdType="pubmed">38017395</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehfeld A.S., Buda S., Haas W., Hauer B., Schulze-Wundling K., Buchholz U. The Changing Symptom Profile of COVID-19 During the Pandemic-Results From the German Mandatory Notification System. Dtsch. Ärztebl. Int. 2023;120:420–421. doi: 10.3238/arztebl.m2023.0018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2023.0018</ArticleId><ArticleId IdType="pmc">PMC10437038</ArticleId><ArticleId IdType="pubmed">37563873</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez Chamorro E., Díez Tascón A., Ibáñez Sanz L., Ossaba Vélez S., Borruel Nacenta S. Radiologic diagnosis of patients with COVID-19. Radiologia. 2021;63:56–73. doi: 10.1016/j.rx.2020.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rx.2020.11.001</ArticleId><ArticleId IdType="pmc">PMC7685043</ArticleId><ArticleId IdType="pubmed">33339622</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrana S.H., Som A., Ndakwah G.S., Yeung T., Febbo J., Heeger A.P., Lang M., McDermott S., Mendoza D.P., Zhang E.W., et al. Comparison of Chest CT Findings of COVID-19, Influenza, and Organizing Pneumonia: A Multireader Study. Am. J. Roentgenol. 2021;217:1093–1102. doi: 10.2214/AJR.21.25640.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.21.25640</ArticleId><ArticleId IdType="pubmed">33852360</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y., Kang M., Shin D.H., Jung J., Choi S.J., Kim N.H., Moon S.M., Song K.H., Kim E.S., Kim H.B. Antibiotic Prescription in Patients With Coronavirus Disease 2019: Analysis of National Health Insurance System Data in the Republic of Korea. J. Korean Med. Sci. 2023;38:e189. doi: 10.3346/jkms.2023.38.e189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e189</ArticleId><ArticleId IdType="pmc">PMC10293658</ArticleId><ArticleId IdType="pubmed">37365725</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachour S.P., Dalal R., Allegretti J.R. The impact of the COVID-19 pandemic on. Therap. Adv. Gastroenterol. 2023;16:17562848231165581. doi: 10.1177/17562848231165581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848231165581</ArticleId><ArticleId IdType="pmc">PMC10107020</ArticleId><ArticleId IdType="pubmed">37091531</ArticleId></ArticleIdList></Reference><Reference><Citation>Portmann L., de Kraker M.E.A., Fröhlich G., Thiabaud A., Roelens M., Schreiber P.W., Troillet N., Iten A., Widmer A., Harbarth S., et al. Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland. JAMA Netw. Open. 2023;6:e2255599. doi: 10.1001/jamanetworkopen.2022.55599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.55599</ArticleId><ArticleId IdType="pmc">PMC9932839</ArticleId><ArticleId IdType="pubmed">36790812</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022–2023. JAMA. 2023;329:1697–1699. doi: 10.1001/jama.2023.5348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.5348</ArticleId><ArticleId IdType="pmc">PMC10080400</ArticleId><ArticleId IdType="pubmed">37022720</ArticleId></ArticleIdList></Reference><Reference><Citation>Monamele G.C., Tsafack D.T., Bilounga C.N., Njankouo Ripa M., Nsangou Yogne C., Munshili Njifon H.L., Nkom F., Tamoufe U., Esso L., Koro Koro F., et al. The Detection of Influenza Virus Before and During the COVID-19 Pandemic in Cameroon. Influenza Other Respir. Viruses. 2024;18:e13313. doi: 10.1111/irv.13313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13313</ArticleId><ArticleId IdType="pmc">PMC11099883</ArticleId><ArticleId IdType="pubmed">38757747</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak M.D., Sordillo E.M., Gitman M.R., Paniz Mondolfi A.E. Coinfection in SARS-CoV-2 infected patients: Where are influenza virus and rhinovirus/enterovirus? J. Med. Virol. 2020;92:1699–1700. doi: 10.1002/jmv.25953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25953</ArticleId><ArticleId IdType="pmc">PMC7267652</ArticleId><ArticleId IdType="pubmed">32352574</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampros A., Talla C., Diarra M., Tall B., Sagne S., Diallo M.K., Diop B., Oumar I., Dia N., Sall A.A., et al. Shifting Patterns of Influenza Circulation during the COVID-19 Pandemic, Senegal. Emerg. Infect. Dis. 2023;29:1808–1817. doi: 10.3201/eid2909.230307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2909.230307</ArticleId><ArticleId IdType="pmc">PMC10461650</ArticleId><ArticleId IdType="pubmed">37610149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi Z., Mansuri Z., Bansod S. Potential Interactions of Remdesivir with Pulmonary Drugs: A Covid-19 Perspective. SN Compr. Clin. Med. 2020;2:1707–1708. doi: 10.1007/s42399-020-00462-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00462-2</ArticleId><ArticleId IdType="pmc">PMC7441835</ArticleId><ArticleId IdType="pubmed">32864571</ArticleId></ArticleIdList></Reference><Reference><Citation>Z endehdel A., Bidkhori M., Ansari M., Jamalimoghaddamsiyahkali S., Asoodeh A. Efficacy of oseltamivir in the treatment of patients infected with COVID-19. Ann. Med. Surg. 2022;77:103679. doi: 10.1016/j.amsu.2022.103679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103679</ArticleId><ArticleId IdType="pmc">PMC9054703</ArticleId><ArticleId IdType="pubmed">35531426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders J.M., Monogue M.L., Jodlowski T.Z., Cutrell J.B. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;323:1824–1836. doi: 10.1001/jama.2020.6019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6019</ArticleId><ArticleId IdType="pubmed">32282022</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi M. Post-viral sequelae of COVID-19 and influenza. Lancet Infect. Dis. 2024;24:218–219. doi: 10.1016/S1473-3099(23)00762-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00762-4</ArticleId><ArticleId IdType="pubmed">38104584</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>